2000
Glycoprotein Exchange Vectors Based on Vesicular Stomatitis Virus Allow Effective Boosting and Generation of Neutralizing Antibodies to a Primary Isolate of Human Immunodeficiency Virus Type 1
Rose N, Roberts A, Buonocore L, Rose J. Glycoprotein Exchange Vectors Based on Vesicular Stomatitis Virus Allow Effective Boosting and Generation of Neutralizing Antibodies to a Primary Isolate of Human Immunodeficiency Virus Type 1. Journal Of Virology 2000, 74: 10903-10910. PMID: 11069984, PMCID: PMC113169, DOI: 10.1128/jvi.74.23.10903-10910.2000.Peer-Reviewed Original ResearchConceptsRecombinant VSV vectorVesicular stomatitis virusNeutralizing antibodiesPrimary isolatesVSV vectorsHigh-titer neutralizing antibodiesHuman immunodeficiency virus type 1Human immunodeficiency virus envelope proteinImmunodeficiency virus type 1HIV primary isolatesCross-neutralizing antibodiesRecombinant vesicular stomatitis virusVirus type 1Effective vaccine vectorAntibody titersWild-type vesicular stomatitis virusHIV envelopeForeign antigensImmune responseVirus envelope proteinVSV Indiana serotypeVaccine vectorType 1AntibodiesG protein gene
1985
Vaccinia Virus Recombinants: Expression of VSV Genes and Protective Immunization of Mice and Cattle
Mackett M, Yilma T, Rose J, Moss B. Vaccinia Virus Recombinants: Expression of VSV Genes and Protective Immunization of Mice and Cattle. Science 1985, 227: 433-435. PMID: 2981435, DOI: 10.1126/science.2981435.Peer-Reviewed Original ResearchConceptsVesicular stomatitis virusLive recombinant virusIntradermal vaccinationIntravenous challengeLethal encephalitisProtective immunizationVaccinia virus promoterDegree of protectionVaccinationContagious diseaseG proteinsStomatitis virusMiceMessenger RNAAntibodiesRecombinant virusesVirus promoterVirusVSV genesN proteinDNA copies